Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$903M |
| 2 |
Apple
AAPL
|
+$843M |
| 3 |
Warner Bros
WBD
|
+$615M |
| 4 |
Home Depot
HD
|
+$580M |
| 5 |
Amazon
AMZN
|
+$403M |
Top Sells
| 1 |
AT&T
T
|
+$770M |
| 2 |
CERN
Cerner Corp
CERN
|
+$600M |
| 3 |
PBCT
People's United Financial Inc
PBCT
|
+$169M |
| 4 |
Marathon Petroleum
MPC
|
+$158M |
| 5 |
S&P Global
SPGI
|
+$154M |
Sector Composition
| 1 | Technology | 23.96% |
| 2 | Healthcare | 14.75% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
3501
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $842K | ﹤0.01% |
436,319
-369,794
| -46% | -$714K |
|
3502
Amtech Systems
ASYS
$126M
| $839K | ﹤0.01% |
114,951
+1,775
| +2% | +$13K |
|
3503
First Capital
FCAP
$145M
| $839K | ﹤0.01% |
30,986
+4,182
| +16% | +$113K |
|
3504
Algoma Steel
ASTL
$488M
| $837K | ﹤0.01% |
93,349
+37,678
| +68% | +$338K |
|
3505
AquaBounty Technologies
AQB
$4.46M
| $836K | ﹤0.01% |
24,459
-31,839
| -57% | -$1.09M |
|
|
BBLN
3506
DELISTED
Babylon Holdings Limited
BBLN
| $834K | ﹤0.01% |
+34,120
| New | +$834K |
|
3507
Passage Bio
PASG
$22.2M
| $830K | ﹤0.01% |
17,586
-14,680
| -45% | -$693K |
|
3508
Assembly Biosciences
ASMB
$171M
| $828K | ﹤0.01% |
32,882
+1,360
| +4% | +$34.2K |
|
3509
Actinium Pharmaceuticals
ATNM
$50.2M
| $828K | ﹤0.01% |
172,217
+5,045
| +3% | +$24.3K |
|
3510
Precision BioSciences
DTIL
$58.9M
| $828K | ﹤0.01% |
17,265
-13,229
| -43% | -$634K |
|
3511
Anixa Biosciences
ANIX
$97.3M
| $826K | ﹤0.01% |
270,003
+779
| +0.3% | +$2.38K |
|
3512
Rush Enterprises Class B
RUSHB
$4.4B
| $826K | ﹤0.01% |
24,990
+4,564
| +22% | +$151K |
|
3513
United Bancorp
UBCP
$84.8M
| $824K | ﹤0.01% |
50,307
+613
| +1% | +$10K |
|
|
BIOR
3514
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $816K | ﹤0.01% |
4,668
+54
| +1% | +$9.44K |
|
3515
Asure Software
ASUR
$220M
| $811K | ﹤0.01% |
142,363
+2,453
| +2% | +$14K |
|
3516
Phunware
PHUN
$54.3M
| $811K | ﹤0.01% |
15,029
+264
| +2% | +$14.2K |
|
3517
QuickLogic
QUIK
$86.6M
| $807K | ﹤0.01% |
95,228
+5,578
| +6% | +$47.3K |
|
3518
Stereotaxis
STXS
$256M
| $807K | ﹤0.01% |
438,890
-367,309
| -46% | -$675K |
|
3519
Cytosorbents Corp
CTSO
$59.3M
| $805K | ﹤0.01% |
367,610
-335,105
| -48% | -$734K |
|
3520
NextCure
NXTC
$14.7M
| $803K | ﹤0.01% |
14,251
+1,600
| +13% | +$90.2K |
|
3521
ICICI Bank
IBN
$114B
| $800K | ﹤0.01% |
45,139
+20,145
| +81% | +$357K |
|
3522
Cooper-Standard Automotive
CPS
$685M
| $799K | ﹤0.01% |
160,133
-111,865
| -41% | -$558K |
|
3523
GT Biopharma
GTBP
$2.65M
| $799K | ﹤0.01% |
8,910
-3,170
| -26% | -$284K |
|
3524
Fiverr
FVRR
$878M
| $795K | ﹤0.01% |
23,144
-136,805
| -86% | -$4.7M |
|
3525
Innovative Solutions & Support
ISSC
$199M
| $793K | ﹤0.01% |
110,146
+36,227
| +49% | +$261K |
|